| 0000-00-00 |
|
|
|
External link to document |
| 2020-06-08 |
1 |
Complaint |
This is an action for patent infringement of U.S. Patent Nos. 9,867,815; 10,016,407;
and 10,420,760 (collectively….
15. United States Patent No. 10,016,407 (the “’407 patent”), titled “Pharmaceutical
Compositions… THE PATENTS-IN-SUIT
12. United States Patent No. 9,867,815 (the “’815 patent”), titled…collectively, “the Patents-in-Suit”) under the patent laws of the United States,
Title 35, United States…1338
because this is a patent infringement action that arises under the patent laws of the United States |
External link to document |
| 2020-07-24 |
14 |
Declaration |
–18 of U.S. Patent No. 9,867,815; and claims 2–5 and 12–15 of U.S. Patent
No. 10,016,407 arising from…2020
20 October 2021
1:20-cv-00770
830 Patent
Plaintiff
District Court, D. Delaware |
External link to document |
| 2020-08-28 |
28 |
Brief - Reply |
10,016,407
(“the ’407 patent”); and claims 1, 4, 7–12, 15, and 18–20 of U.S. Patent No. 10,420,760 (“… U.S. Patent
No. 9,867,815 (“the ’815 patent”); claims 1, 6, 9-11, 16, 19, and 20 of U.S. Patent No. 10,016,407…of the ’815 patent and claims 2–5, and 12–15 of
the ’407 patent, (2) the Unasserted Patents, and (3) C-Topical…Genus sued
Lannett for patent infringement on specific claims of three patents.1 In response, Lannett …(“the ’760
patent”) (collectively, “the Asserted Patents” and “the Asserted Claims”).
2
Lannett’s Memorandum |
External link to document |
